- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03424343
Longitudinal Identity Study of Childhood Cancer Survivors (LInC)
February 5, 2024 updated by: Koen Luyckx, KU Leuven
The Long-term Impact of Pediatric Cancer on Adolescents, Emerging Adults, and Their Family: Identity, Psychosocial Functioning, and Development
The study investigators plan to conduct a longitudinal questionnaire study in adolescents and emerging adults (14-25 years of age at the start of the study) who survived childhood cancer to chart their identity development and broader social functioning.
Additionally, the functioning of these survivors will be related to the functioning of their parents and siblings.
The investigators shall focus especially on the current experience and impact of the earlier cancer experience.
They will investigate to what extent the experience of a life-threatening disease has an effect on the daily life of survivors and over time and how the survivors develop through the course of adolescence and emerging adulthood on the psychosocial level.
The formation of an adult identity is a very challenging task during adolescence and the way to adulthood and the fact that these youth had cancer during their childhood may especially complicate this process of identity formation.
Furthermore, both parental and sibling functioning will be taken into account, which will allow us to examine inter-generational mechanisms (thus parental functioning that possibly impacts youth functioning and vice versa) and sibling functioning in these families.
To investigate the latter, at each timepoint of the longitudinal study a sibling between 14 and 25 years of age at the start of the study will be included (if there is more than one sibling in a family, ideally the sibling who is closest in age will be the one who participates in the study).
Moreover, a community sample that is matched on age and sex with the survivor of pediatric cancer will be assessed.
This will allow the investigators to make well-founded comparisons regarding identity development and broader psychosocial functioning.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
In the present longitudinal study, four main research questions will be investigated.
- How does identity develop in cancer survivors? Based on previous findings from studies in identity development, it seems that young adults with a chronic disease like type 1 diabetes show less exploration or consider less identity possibilities from which they can choose, e.g. they dwell less upon the choice of education. Does this finding also apply to survivors of childhood cancer or are these youth more similar to a community sample? This research question may provide an answer to the question whether or not there is a continued (psychological) impact of childhood cancer on the later identity development of survivors. For this purpose the investigators shall make use of an identity model which was developed at their research department and which has gained much international research attention. In addition, the investigators want to look at illness-identity, which comprises the amount to which the earlier cancer experience is integrated into one's identity. Does the youngster feel still engulfed by the earlier cancer experience, or has he/she integrated this experience as part of his/her self-concept? Or does the youngster feel even enriched by the earlier cancer experience, thus did he/she end up even stronger through the experience?
- How do survivors of pediatric cancer and/or their parents function on the psychological level, more specific on the level of life satisfaction and depressive symptoms, and what is the role of identity and personality variables herein? This question examines, among other factors, concepts like benefit-finding, post-traumatic growth, resilience,... Thereby it would be interesting to examine whether different subgroups can be identified, for example, which groups of persons display less adaptive functioning and why?
- Are there certain parenting dimensions (e.g. overprotection, responsiveness, psychological control,...) which are more prevalent in families that were confronted with pediatric cancer and are these dimensions differently related to the psychosocial adaptation of survivors? Does this relate to certain aspects of survivor functioning, like depressive symptoms and quality of life? Thereby, transactional processes between survivor and parental functioning will be investigated, e.g. does identity development of survivors have an impact on parental well-being, and has parental well-being in turn an impact on survivor functioning? Taken together, the investigators want to investigate to what extent these contextual variables determine the functioning of adolescents and emerging adults.
- What is the impact for siblings of cancer survivors? How do they go through their identity process? Do they experience the same parenting as the survivors experience themselves? E.g if survivors would experience more parental overprotection, would siblings experience overprotection to the same extent?
Study Type
Observational
Enrollment (Actual)
126
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgium, 3000
- Gasthuisberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Survivors of childhood cancer, treated at the department of pediatric oncology at UZ Leuven.
Description
Inclusion Criteria:
- Survivors of childhood leukemia/lymphoma, solid tumors, and brain tumors, of whom the treatment has ended.
- 14-25 years at the start of the study
- Treated at the department of pediatric oncology at University Hospital Leuven, Belgium.
- Sufficient knowledge of Dutch
Exclusion Criteria:
- Mental retardation which hinders completion of the questionnaire bundle
- Younger than 14 year and older than 25 year
- Physically incapable to complete the questionnaire bundle
- Insufficient knowledge of Dutch
- Contact information is not available
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
cancer survivor, parents, sibling
study samples adolescent and young adult survivors of pediatric cancer, their parents, and one sibling; they are assessed using self-report questionnaires, so no intervention takes place
|
Questionnaires on identity formation and psychosocial functioning, assessed and reported at baseline, one year later, two years later, and five years later.
After obtaining informed consent, we will access the medical file of participants to obtain information on the diagnosis, time of diagnosis, treatment duration, type of treatment, and relapse (when applicable).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Dimensions of Identity Development
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Dimensions of Identity Development Scale (DIDS); dimensions: commitment making (range: 5 - 25), Identification with Commitment (range: 5 - 25), Exploration in Breadth (rang: 5 - 25), Exploration in Depth (range: 5 - 25), Ruminative Exploration (range: 5 - 25); for each dimension, a higher score indicates more identification with the dimension
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Identity from an Eriksonian Perspective
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Erikson Psychosocial Stage Inventory (EPSI); subscales: Synthesis (range: 5 - 30), Confusion (range: 5 - 30); for each scale, higher scores indicate more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Illness Centrality
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Illness Centrality; total scale range: 0 - 4; A higher score indicates more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Self-Identity after Cancer
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Self-Identity after Cancer; dimensions: victim of cancer (range: 1 - 5), cancer patient (range: 1 - 5), person who had cancer (range: 1 - 5), survivor (range: 1 - 5); for each dimension, a higher score indicates more identification with the dimension
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Post-Traumatic Stress Symptoms (measured in survivors)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Children's Revised Impact of Event Scale (CRIES-13); total scale range: 0 - 65; Higher scores indicate more sensitivity for PTSD; A score higher than 30 possibly indicates the presence of PTSD; subscales: Intrusion (range: 0 - 20), Avoidance (range: 0 - 20), Arousal (range: 0 - 25); Higher scores indicate more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Illness-related Benefit Finding (measured in survivors)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Benefit scale from the Benefit and Burden Scale (BBSC); total scale range: 10 - 50; A higher score indicates more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Depressive Symptoms (measured in survivors, siblings, and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Center for Epidemiologic Studies Depression (CES-D-12); total scale range: 0 - 36; a higher score indicates the presence of more depressive symptoms
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Cancer-related Worries (measured in survivors and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Cancer Related Worries Scale; total scale range: 4 - 20; A higher score indicates the presence of more cancer-related worries
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Global Life Satisfaction (measured in survivors, siblings and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Satisfaction with Life Scale (SWLS); total scale range: 5 - 35; A higher score indicates more satisfaction with life
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Bodily Functioning (measured in survivors)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Short Form 36, physical subscale (SF-36); total scale range: 10 - 30: A higher score indicates worse bodily functioning
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Self-Esteem (measured in survivors, siblings, and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Rosenberg Self-Esteem Scale (RSES); total scale range: 10 - 40: A higher score indicates higher self-esteem
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Resilience (measured in survivors and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Brief Resilience Scale (BRS); total scale range: 6 - 30; A higher score corresponds to being more resilient
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Personality (measured in survivors and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Big Five Inventory 10 (BFI-10); subscales: Extraversion (range: 2 - 10), Agreeableness (range: 2 - 10), Conscientiousness (range: 2 - 10), Neuroticism (range: 2 - 10), Openness (range: 2 - 10); for each scale, a higher score indicates more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Self-Harm (measured in survivors)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Based on Goossens et al., 2013: Health risk behaviors in adolescents and emerging adults with congenital heart disease: psychometric properties of the Health Behavior Scale-Congenital Heart Disease
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Perception of Control (measured in survivors, siblings, and parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Multidimensional Health Locus of Control Scale (MHLCS): subscales: Internal Health Locus of Control (range 6 - 36), Powerful Others Health Locus of Control (range 6 - 36), Chance Health Locus of Control (range: 6 - 36); for each scale, a higher score indicates more identification with the scale
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Social Support (measured in survivors and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Multidimensional Scale of Perceived Social Support (MSPSS); subscales: support from special someone (range: 4 - 28), support from family (range: 4 - 28), support from friends (range: 4 - 28); for each subscale, a higher score indicates more support
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Contact with Peer Survivors (measured in survivors)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Self-constructed questionnaire
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Parental Behavioral Control (measured in survivors, parents, and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Based on the 8-item Parental Expectations for Behavior Scale and the 8-item Parental Monitoring of Behavior Scale uit de 'Parental Regulation Scale - Youth Self-Report' (PRS -YSR; Barber, 2002); Behavioral Control; total scale range: 7 - 35; A higher score indicates more parental behavioral control
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Parental Responsiveness (measured in survivors, parents, and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Child Report of Parent Behavior Inventory (CRPBI; Schaefer, 1965; Schludermann & Schludermann, 1988); Responsiveness; total scale range: 7 - 35; A higher score indicates more parental responsiveness
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Parental Overprotection (measured in survivors, parents, and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
based on Dutch Multidimensional Overprotective Parenting Scale, Kins & Soenens, 2013; Overprotection / anxious parenting; Overprotection; total scale range: 8 - 40; A higher score indicates more parental overprotection
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Parental Psychological Control (measured in survivors, parents, and siblings)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
8-item Psychological Control Scale-Youth Self-Report ( Barber, 1996); Psychological Control; total scale range: 8 - 40; A higher score indicates more parental psychological control
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Illness Intrusiveness (measured in parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Illness Intrusiveness Questionnaire Parent Report (IIQ-Parent Report); total scale range: 13 - 91; A higher score indicates more illness intrusiveness
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Parental competence (measured in parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Parenting Stress Index - Sense of Competence Scale; total scale range: 13 - 78; A higher score indicates a lower sense of parental competence
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Role Restriction (measured in parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Parental Burden Questionnaire, subscale role restriction; total scale range: 6 - 24; A higher score indicates a greater sense of role restriction
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Relationship Quality (measured in parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Family Functioning Questionnaire, subscale parental relationship quality; total scale range: 5 - 20; A higher score indicates a greater sense of partner relationship quality
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Change in Benefit Finding (measured in parents)
Time Frame: Assessed and reported at baseline, one year later, two years later, and five years later
|
Benefit Finding Scale; total scale range: 15 - 105; A higher score indicates more benefit finding
|
Assessed and reported at baseline, one year later, two years later, and five years later
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Koen Luyckx, Dr., KU Leuven
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 28, 2018
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
March 1, 2024
Study Registration Dates
First Submitted
November 29, 2017
First Submitted That Met QC Criteria
January 31, 2018
First Posted (Actual)
February 7, 2018
Study Record Updates
Last Update Posted (Estimated)
February 7, 2024
Last Update Submitted That Met QC Criteria
February 5, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S60535
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationUnknownCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Alexandria UniversityCompletedPediatric Cancer | Invasive CancerEgypt
-
University of California, San DiegoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsNot yet recruiting
-
Immune Oncology Research InstituteRecruitingContinuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With DexamethasonePediatric CancerArmenia
-
Connecticut Children's Medical CenterThe Hospital for Sick ChildrenRecruitingPediatric CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingPediatric CancerUnited States
-
Erin RowellRecruiting
-
Giselle ShollerRecruiting
Clinical Trials on Questionnaire bundle
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); University of MinnesotaCompletedCigarette SmokingUnited States
-
Oslo University HospitalCompleted
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingInfant | Intubation ComplicationUnited States, Canada
-
University Medical Centre LjubljanaRecruitingBundle-Branch Block | AV Block | Atrial Fibrillation RapidSlovenia
-
Peking University Third HospitalThe First Affiliated Hospital of Anhui Medical University; The Affiliated Nanjing...Completed
-
Tampere University HospitalCompleted
-
Peking University Third HospitalUnknownRupture of Anterior Cruciate Ligament
-
Florida State UniversityDuquesne UniversityRecruitingSocial CommunicationUnited States
-
University of California, San FranciscoAmerican Academy of PediatricsCompleted
-
University Medical Centre MariborActive, not recruitingAnterior Cruciate Ligament ReconstructionSlovenia